➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Dow
Boehringer Ingelheim
Medtronic
Harvard Business School

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Quinapril Hydrochloride And Hydrochlorothiazide patents expire, and when can generic versions of Quinapril Hydrochloride And Hydrochlorothiazide launch?

Quinapril Hydrochloride And Hydrochlorothiazide is a drug marketed by Apotex Corp, Aurobindo Pharma, Invagen Pharms, Mylan, and Sun Pharm Inds Ltd. and is included in five NDAs.

The generic ingredient in QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.

Summary for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
LaborMed Pharma S.A.Phase 4
National Center for Research Resources (NCRR)Phase 4
Vanderbilt University Medical CenterPhase 4

See all QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Corp QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 091524-001 Mar 12, 2013 AB RX No No   Start Trial   Start Trial   Start Trial
Invagen Pharms QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 201356-001 Apr 20, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Aurobindo Pharma QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; quinapril hydrochloride TABLET;ORAL 078450-001 Aug 24, 2007 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Merck
Baxter
Boehringer Ingelheim
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.